Skip to main content
Erschienen in: Pediatric Cardiology 8/2013

01.12.2013 | Case Report

Jervell and Lange–Nielsen Syndrome: Homozygous Missense Mutation of KCNQ1 in a Turkish Family

verfasst von: Ozlem Bostan, Şehime G. Temel, Hakan Cangül, Caroline N. S. Archer, Ergun Çil

Erschienen in: Pediatric Cardiology | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Long QT syndrome is one of the most common cardiac ion channel diseases, but its morbidity and mortality rate can be lessened with an early diagnosis and proper treatment. This cardiac ventricular repolarization abnormality is characterized by a prolonged QT interval and a propensity for ventricular tachycardia (VT) of the torsades de pointes type. The long QT syndrome represents a high risk for presyncope, syncope, cardiac arrest, and sudden death. Jervell and Lange–Nielsen syndrome (JLNS) is a recessively inherited form of long QT syndrome characterized by profound sensorineural deafness and prolongation of the QT interval. Findings have shown that JLNS occurs due to homozygous and compound heterozygous pathogenic variants in KCNQ1 or KCNE1. A 3.5-year-old girl presented to the hospital with recurrent syncope, seizures, and congenital sensorineural deafness. Her electrocardiogram showed a markedly prolonged QT interval, and she had a diagnosis of JLNS. The sequence analysis of the proband showed the presence of a pathogenic homozygous missense variant (c.728G>A, p.Arg243His). Heterozygous mutations of KCNQ1 were identified in her mother, father, and sister, demonstrating true homozygosity. Even with high-dose beta-blocker therapy, the patient had two VT attacks, so an implantable cardioverter defibrillator was fitted. The authors suggest early genetic diagnosis for proper management of the disease in the proband and genetic counseling for both the proband and the girl’s extended family.
Literatur
1.
Zurück zum Zitat Chouabe C, Neyroud N, Richard P, Denjoy I, Hainque B, Romey G et al (2000) Novel mutations in KvLQT1 that affect IKs activation through interactions with Isk. Cardiovasc Res 45:971–980CrossRefPubMed Chouabe C, Neyroud N, Richard P, Denjoy I, Hainque B, Romey G et al (2000) Novel mutations in KvLQT1 that affect IKs activation through interactions with Isk. Cardiovasc Res 45:971–980CrossRefPubMed
2.
Zurück zum Zitat Franqueza L, Lin M, Splawski I, Keating MT, Sanguinetti MC (1999) Long QT syndrome-associated mutations in the S4–S5 linker of.KvLQT1 potassium channels modify gating and interaction with minK subunits. J Biol Chem 274:21063–21070CrossRefPubMed Franqueza L, Lin M, Splawski I, Keating MT, Sanguinetti MC (1999) Long QT syndrome-associated mutations in the S4–S5 linker of.KvLQT1 potassium channels modify gating and interaction with minK subunits. J Biol Chem 274:21063–21070CrossRefPubMed
3.
Zurück zum Zitat Goyal JP, Sethi A, Shah VB (2012) Jervell and Lange–Nielsen syndrome masquerading as intractable epilepsy. Ann Ind Acad Neurol 15:145–147CrossRef Goyal JP, Sethi A, Shah VB (2012) Jervell and Lange–Nielsen syndrome masquerading as intractable epilepsy. Ann Ind Acad Neurol 15:145–147CrossRef
4.
Zurück zum Zitat Jervell A, Lange–Nielsen F (1957) Congenital deaf-mutism, functional heart disease with prolongation of Q–T interval and sudden death. Am Heart J 54:59–68CrossRefPubMed Jervell A, Lange–Nielsen F (1957) Congenital deaf-mutism, functional heart disease with prolongation of Q–T interval and sudden death. Am Heart J 54:59–68CrossRefPubMed
5.
Zurück zum Zitat Kannankeril PJ, Fish FA (2008) Disorders of cardiac rhythm and conduction. In: Allen HD, Driscoll DJ, Shaddy RE, Feltes TF (eds) Moss and Adams’ heart disease in infants, children, and adolescents including the fetus and young adult, 7th edn. Lippincott Williams & Wilkins, Philadelphia, pp 328–331 Kannankeril PJ, Fish FA (2008) Disorders of cardiac rhythm and conduction. In: Allen HD, Driscoll DJ, Shaddy RE, Feltes TF (eds) Moss and Adams’ heart disease in infants, children, and adolescents including the fetus and young adult, 7th edn. Lippincott Williams & Wilkins, Philadelphia, pp 328–331
6.
Zurück zum Zitat MacCormick JM, McAlister H, Crawford J, French JK, Crozier I, Shelling AN, Eddy C, Rees MI, Skinner JR (2009) Misdiagnosis of long QT syndrome as epilepsy at first presentation. Ann Emerg Med 54:26–32CrossRefPubMed MacCormick JM, McAlister H, Crawford J, French JK, Crozier I, Shelling AN, Eddy C, Rees MI, Skinner JR (2009) Misdiagnosis of long QT syndrome as epilepsy at first presentation. Ann Emerg Med 54:26–32CrossRefPubMed
7.
Zurück zum Zitat Mohammad-Panah R, Demolombe S, Neyroud N et al (1999) Mutations in dominant-negative isoform correlate with phenotype in inherited cardiac arrhythmias. Am J Hum Genet 64:1015–1023PubMedCentralCrossRefPubMed Mohammad-Panah R, Demolombe S, Neyroud N et al (1999) Mutations in dominant-negative isoform correlate with phenotype in inherited cardiac arrhythmias. Am J Hum Genet 64:1015–1023PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Park K, Piron J, Dahimene S, Me’rot J, Baro L, Escande D, Loussouarnet G (2005) Impaired KCNQ1–KCNE1 and phosphatidylinositol-4,5-bisphosphate interaction underlies the long QT syndrome. Circ Res 96:730–739CrossRefPubMed Park K, Piron J, Dahimene S, Me’rot J, Baro L, Escande D, Loussouarnet G (2005) Impaired KCNQ1–KCNE1 and phosphatidylinositol-4,5-bisphosphate interaction underlies the long QT syndrome. Circ Res 96:730–739CrossRefPubMed
9.
10.
Zurück zum Zitat Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, Robinson JL, Moss AJ, Schwartz PJ, Toebin JA, Vincent MG, Keating MT (2000) Spectrum of mutations in long-QT syndrome genes KVLQT1, HERG, SCN5A, KCNE, and KCNE2. Circulation 102:1178–1185CrossRefPubMed Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, Robinson JL, Moss AJ, Schwartz PJ, Toebin JA, Vincent MG, Keating MT (2000) Spectrum of mutations in long-QT syndrome genes KVLQT1, HERG, SCN5A, KCNE, and KCNE2. Circulation 102:1178–1185CrossRefPubMed
11.
Zurück zum Zitat Tyson J, Tranebjaerg L, McEntagart M, Larsen LA, Christiansen M, Whiteford ML, Bathen J, Aslaksen B, Sørland SJ, Lund O, Pembrey ME, Malcolm S (2001) Mutational spectrum in the cardioauditory syndrome of Jervell-Lange & Nielsen syndrome. Erratum in Hum Genet 2001; 108:75. Hum Genet 107:499–503CrossRef Tyson J, Tranebjaerg L, McEntagart M, Larsen LA, Christiansen M, Whiteford ML, Bathen J, Aslaksen B, Sørland SJ, Lund O, Pembrey ME, Malcolm S (2001) Mutational spectrum in the cardioauditory syndrome of Jervell-Lange & Nielsen syndrome. Erratum in Hum Genet 2001; 108:75. Hum Genet 107:499–503CrossRef
12.
Zurück zum Zitat Ward OC (1964) A new familial cardiac syndrome in children. J Ir Med Assoc 54:103–106PubMed Ward OC (1964) A new familial cardiac syndrome in children. J Ir Med Assoc 54:103–106PubMed
Metadaten
Titel
Jervell and Lange–Nielsen Syndrome: Homozygous Missense Mutation of KCNQ1 in a Turkish Family
verfasst von
Ozlem Bostan
Şehime G. Temel
Hakan Cangül
Caroline N. S. Archer
Ergun Çil
Publikationsdatum
01.12.2013
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 8/2013
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-013-0634-3

Weitere Artikel der Ausgabe 8/2013

Pediatric Cardiology 8/2013 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.